GRM3 and Anxiety: Furthermore, the anxiolytic effects of the group II agonists are absent or reduced in single GRM2−/− and GRM3−/− mice (Linden et al., 2005), confirming that the drugs are indeed acting through both of the group II metabotropic glutamate receptor subtypes to reduce anxiety.